Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Lannett Says FDA Completes Review Of IND Application For Biosimilar Insulin Glargine; Stock Surges


RTTNews | Jan 21, 2022 07:00AM EST

06:59 Friday, January 21, 2022 (RTTNews) - Lannett Says FDA Completes Review Of IND Application For Biosimilar Insulin Glargine; Stock Surges

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2022 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC